Ehrlich tumor as model to study artificial hyperthyroidism influence on breast cancer

Pathology Research and Practice

Volumn 203, Issue 1, 2007, Pages 39-44

  Ferreira, Enio ^a   da Silva, Alessandra Estrela ^a   Serakides, Rogéria ^a   Gomes, Mardelene Geisa ^a   Cassali, Geovanni Dantas ^a  

^a ICB   (Brazil)

Author keywords

Cancer; Mouse; Thyroid; Thyrotoxicosis; Thyroxine

Indexed keywords

LEVOTHYROXINE; THYROID HORMONE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; AUTOPSY; BREAST CANCER; CANCER CELL; CANCER TRANSPLANTATION; CARCINOGENESIS; CASTRATION; CELL COUNT; CELL METABOLISM; CELL NUCLEUS; CELL PROLIFERATION; CHROMOSOME NOR; CONTROLLED STUDY; EHRLICH ASCITES TUMOR; EXPERIMENTAL MODEL; FEMALE; HISTOPATHOLOGY; HYPOTHYROIDISM; IMMUNOHISTOCHEMISTRY; INOCULATION; MITOSIS; MORPHOLOGY; MORPHOMETRICS; MOUSE; NONHUMAN; TUMOR GROWTH; TUMOR VOLUME;

EID: 33846301736     PISSN: 03440338     EISSN: 16180631     Source Type: Journal    
DOI: 10.1016/j.prp.2006.09.005     Document Type: Article

References (40)

1. Aubele M., Biesterfeld S., and Derenzini M. Guidelines of AgNOR quantitation. Zbl. Pathol. 140 1 (1994) 107-108
2. Bicher H.I., Hetzel F.W., Sandhu T.S., et al. Effects of hyperthermia on normal and tumor microenvironment. Radiology 137 (1980) 523-530
3. Canet V., Montmasson M.P., Usson Y., et al. Correlation between silver-stained nucleolar organizer region area and cell cycle time. Cytometry 43 (2001) 110-116
4. M.L. Dagli, Disseminação linfática do tumor de Ehrlich: estudo experimental, Fac. de Med. Veter. e Zootec. da USP, São Paulo, 1989, 148pp.
5. Derenzini M., Pession A., and Trere D. The quantity of nucleolar silver-stained proteins is related to proliferating activity in cancer cells. Lab. Invest. 63 (1990) 137-140
6. Dinda S., Sanchez A., and Moudgil V. Estrogen-like effects of thyroid hormone on the regulation of tumor suppressor proteins, p53 and retinoblastoma, in breast cancer cells. Oncogene 21 5 (2002) 761-768
7. García-Silva S., and Aranda A. The thyroid hormone receptor is a suppressor of ras-mediated transcription, proliferation, and transformation. Mol. Cellular Biol. 24 17 (2004) 7514-7523
8. García-Silva S., Perez-Juste G., and Aranda A. Cell cycle control by the thyroid hormone in neuroblastoma cells. Toxicology 181-182 (2002) 179-182
9. Goldman M.B. Thyroid diseases and breast cancer. Epidemiol. Rev. 12 (1990) 6-28
10. Gonzalez-Sancho J.M., Figueroa A., Lopez-Barahona M., et al. Inhibition of proliferation and expression of T1 and cyclin D1 genes by thyroid hormone in mammary epithelial cells. Mol. Carcinog. 34 3 (2002) 164
11. J.L. Guerra, Aspectos do processo inflamatório em camundongos portadores do tumor de Ehrlich. São Paulo, 79p./Tese de doutorado-Faculdade de Medicina Veterinária e Zootecnia da USP, 1983.
12. Haschek W.M., and Rousseaux C.G. Handbook of Toxicology Pathology (1991), Academic Press, San Diego 1080pp
13. Henderson B.E., and Feigelson H.S. Hormonal carcinogenesis. Carcinogenesis 21 (2000) 427-433
14. Hinkle P.M., and Kinsella P.A. Thyroid hormone induction of an autocrine growth factor secreted by pituitary tumor cells. Science 234 4783 (1986) 1549-1552
15. Hirooka Y., Shiota S., Matsui T., et al. The effects of hyperthermia on the cell cycle of Ehrlich ascites cancer cells in vivo. Jpn. J. Surg. 20 4 (1990) 437-442
16. Kariv R., Enden A., Zvibel I., et al. Triiodothyronine and interleukin-6 (IL-6) induce expression of HGF in an immortalized rat hepatic stellate cell line. Liver Int. 23 3 (2003) 187-193
17. Kazer R.R. Insulin resistance, insulin-like growth factor I and breast cancer: a hypothesis. Int. J. Cancer 62 (1995) 403-406
18. Kodama M., and Kodama T. Effects of steroid hormones on the in vivo incorporation of glycine-2 14 C into Ehrlich solid tumor, kidney, and liver. Cancer Res. 30 (1970) 228-235
19. Kodama M., and Kodama T. Statistical analysis of hormonal effects on the steroid responsiveness of Ehrlich solid tumors. Cancer Res. 30 (1970) 221-227
20. Ledda-Columbano G.M., Perra A., and Pibiri M. Induction of pancreatic acinar cell proliferation by thyroid hormone. J. Endocrinol. 185 3 (2005) 393-399
21. Loeser A.A. A new therapy for prevention of post-operative recurrences in genital and breast cancer: a six-years study of prophylactic thyroid treatment. Br. J. Cancer 2 (1954) 1380-1383
22. Lorenzato M., Abboud P., Lechki C., et al. Proliferation assessment in breast cancer: a double-staining technique for AgNOR quantification in MIB-1 positive cells especially adapted for image cytometry. Micron 31 (2000) 151-159
23. Luna L.G. Manual of histologic staining methods of the Armed Forces Institute of Pathology. third ed (1968), McGraw-Hill, New York 258pp
24. Martinez M.B., Ruan M., and Fitzpatrick L.A. Altered response to thyroid hormones by prostate and breast cancer cells. Cancer Chemother. Pharmacol. 45 (2000) 93-102
25. Martinez M.B., Ruan M., and Fitzpatrick L.A. Altered response to thyroid hormones by breast and ovarian cancer cells. Anticancer Res. 20 6B (2000) 4141-4146
26. Nogueira C.R., and Brentani M.M. Triiodothyronine mimics the effects of estrogen in breast cancer cell lines. J. Steroid Biochem Mol. Biol. 59 3-4 (1996) 271-279
27. F.C.H. Pinto, Possíveis mecanismos envolvidos na supressão do tumor de Ehrlich em camundongos com alergia alimentar. Tese de Doutorado. Belo Horizonte: Escola de medicina - UFMG, 2003, 91pp.
28. Ponder B.A.J. Cancer genetics. Nature 411 (2001) 336-341
29. E.B. Prophet, B. Mills, J.B. Arrington, et al., AFIP Laboratory Methods in Histotechnology, Am. Registry of Pathology, Washington, 1992, 278pp.
30. P.B. Rozenchan, R.A. Roela, Bases biológicas da oncogênese - Hormônios. in: Lopes, A., et al. (Eds.), Oncologia para a graduação, Tecmedd Editora, Ribeirão Preto, SP, 2005, 604pp.
31. I. B. M. Sampaio, Estatística aplicada à experimentação animal, second ed. FEPMVZ, Belo Horizonte, 2002, 265pp.
32. Serakides R., Nunes V.A., Silva C.M., et al. Influência do hipogonadismo na histomorfometria e função tireoidiana de ratas hipotireóideas. Arq. Bras. Med. Vet. Zootec. 54 5 (2002) 69-72
33. Silva A.E., Serakides R., and Ferreira E. Effect of hypothyroidism on the solid form of Ehrlich tumor in intact or castrated adult female mice. Arq. Bras. Endocrinol. Metabol. 48 6 (2004) 867-874
34. Tang H.Y., Lin H.Y., Zhang S., et al. Thyroid hormone causes mitogen-activated protein kinase-dependent phosphorylation of the nuclear estrogen receptor. Endocrinology 145 7 (2004) 3265-3272
35. Trerè D., Pession A., and Derenzini M. The silver stained proteins of interphasic nucleolar organizer regions as a parameter of cell duplication rate. Exp. Cell Res. 184 (1989) 131-137
36. Tutton P.J. The influence of thyroidectomy and of triiodothyronine administration on epithelial cell proliferation in the jejunum of rat. Virchows Arch. B Cell Pathol. 20 2 (1976) 139-142
37. Vorherr H. Thyroid disease in relation to breast cancer. Klin. Wochenschr. 56 (1978) 1136-1145
38. Weiss H.A., Brinton L.A., Potischman X., et al. Breast cancer risk in young women and history of selected medical conditions. Int. J. Epidemiol. 28 (1999) 816-823
39. Wikstrom L., Johansson C., Salto C., et al. Abnormal heart rate and body temperature in mice lacking thyroid hormone receptor alpha 1. EMBO J. 17 (1998) 455-461
40. Zhou-Li F., Albaladejo V., Joly-Pharaboz M.O., et al. Antiestrogens prevent the stimulatory effects of l-triiodothyronine on cell proliferation. Endocrinology 130 3 (1992) 1145-1152